Na Xu

4PUBLICATIONS
26CO-AUTHORS
Haematological tumoursTraditional Chinese medicine and treatmentsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 21, 2025
Venetoclax plus azacitidine with or without homoharringtonine followed by allogeneic haematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukaemia: A multicentre cohort study.

Yiling Ye, Xinyu Liu, Huajuan Dai

|Nov 12, 2024
Homoharringtonine Added to Venetoclax and Azacitidine Improves Outcome and Mitigates Genetic Impact in Relapsed/Refractory AML: A Multicenter Cohort Study.

Guopan Yu, Yu Zhang, Sijian Yu

|May 20, 2024
Allogeneic haematopoietic stem cell transplantation might overcome the poor prognosis of adolescents and adult patients with T-lineage acute lymphoblastic leukaemia and CDKN2 deletion.

Xiaoshan Hu, Zhixiang Wang, Yuting Qin

|Dec 16, 2023
Patient Versus Physician Perspective in the Management of Chronic Myeloid Leukemia During Treatment with Tyrosine Kinase Inhibitors.

Hong Chen, Yan Wen, Yun Zeng

Pageof 1

Frequent Collaborators

3 joint publications

Qifa Liu

2 joint publications

Guopan Yu

2 joint publications

Hua Jin

2 joint publications

Li Xuan